Keith Katkin

SNDX

Keith Katkin serves as Director at Syndax Pharmaceuticals, Inc. (SNDX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$91.1K

Total Sells

3 trades

$926.6K

Net Position

Net Seller

$835.5K

Companies Traded

EBS, SNDX

Active Period

Oct 2022 – May 2025

4 total trades

Most Recent

Sell EBS

May 23, 2025 · $49.4K

Keith Katkin's Insider Trading at Syndax Pharmaceuticals, Inc. (SNDX)

Buys

1 · $91.1K

Sells

2 · $877.2K

Total Shares Bought

10,000

Total Shares Sold

34,000

SNDX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 19, 2025	Buy	10,000	$9.11	$91.1K	0
Oct 7, 2022	Sell	29,899	$25.90	$774.4K	32,000
Oct 4, 2022	Sell	4,101	$25.06	$102.8K	32,000

Keith Katkin's Insider Trading at Emergent BioSolutions Inc. (EBS)

Buys

0 · $0.00

Sells

1 · $49.4K

Total Shares Bought

Total Shares Sold

7,844

EBS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 23, 2025	Sell	7,844	$6.30	$49.4K	0

Related Insiders

Michael A Metzger

director, officer: Chief Executive Officer

SNDXSell · Feb 10, 2026

Keith A. Goldan

officer: Chief Financial Officer

SNDXSell · Feb 10, 2026

Jessica Perl

SVP, General Counsel, Corp Sec

EBSSell · Feb 9, 2026

William Hartzel

SVP, Bioservices

EBSSell · Feb 6, 2026

Coleen Glessner

EVP, Quality & Ethics, and CPL

EBSSell · Feb 6, 2026

Paul Anthony Williams

SVP, Products Business

EBSSell · Feb 6, 2026

LINDAHL RICHARD S

EVP, Chief Financial Officer

EBSSell · Feb 6, 2026

Simon C Lowry

SVP, R&D, CMO

EBSSell · Dec 14, 2025

Explore More Insider Trading Data

SNDX Insider Trading Activity

View all insider trades at Syndax Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity